The Korea Pharmaceutical Manufacturer Association will impose ‘severe disciplinary action’ on companies providing rebates for a large number of drugs with expired patents

Advancing on adoption of ethical management into pharmaceutical companies, the Korea Pharmaceutical Manufacturer Association (KPMA) showed aggressive attitude towards rebates.

While concerns of rebate temptation for a large number of drugs with expired patents have been suggested in the industry, chairman of the KPMA (chairman Soon-tae Jo) held a meeting to decide to have strict enforcement ag...